Decline in mortality in children with HIV in the UK and Ireland
BMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7438.524-a (Published 26 February 2004) Cite this as: BMJ 2004;328:524
Authors' reply
- D M Gibb, reader in epidemiology (mbh@ctu.mrc.ac.uk),
- T Duong, statistician,
- P A Tookey, senior lecturer in paediatric epidemiology
- Medical Research Council Clinical Trials Unit, London NW1 2DA
- Centre for Paediatric Epidemiology and Biostatistics, Institute of Child Health, London WC1N 1EH
EDITOR—Mhlongo and Maduna and Prime et al challenge the results of our study and think that we overlooked alternative reasons for the rapid fivefold decline in mortality, progression to AIDS, and hospital admission rates we reported in the CHIPS cohort of vertically HIV infected children in the United Kingdom and Ireland. We cannot agree that they provide viable alternative explanations for the dramatic reduction.
Firstly, we did not include details of management of opportunistic infections, and we agree that there is indirect evidence that cotrimoxazole prophylaxis reduces the frequency of these (particularly Pneumocystis carinii pneumonia in infancy, as previously reported in the United Kingdom1 …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.